Trial intelligence / Profile preview

KHK7580 in secondary hyperparathyroidism

NCT01935856Phase 2Completed

Sponsor
Kyowa Kirin
Start
Aug 2013
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ASP7991 in secondary hyperparathyroidism (SHPT), sponsored by Kyowa Kirin. Started Aug 2013; status: completed.

02

Drugs

ASP7991
03

Conditions

secondary hyperparathyroidism (SHPT)

Beyond the preview

Go deeper on NCT01935856.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01935856.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call